MonoSol Rx, the developer of PharmFilm drug delivery technology, today announced that it has licensed Zuplenz to Galena Biopharma, a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. Zuplenz is the first oral soluble lingual film p
By a News Reporter-Staff News Editor at Clinical Trials Week According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the inventors Huang, Leaf; Gao, Xiang; Sorgi, Frank L., filed on December 12, 2012, was published online on July 8, 2014. The assignee for this patent, patent number 8771728, is Univers
Research and Markets has announced the addition of the "Global Transdermal Drug Delivery Market 2014-2018" report to its offerings. In a release, Research and Markets noted that report highlights include:. The Global Transdermal Drug Delivery market will grow at a CAGR of 9.9 percent.
By a News Reporter-Staff News Editor at Clinical Trials Week ViaCyte, Inc., a privately held regenerative medicine company developing a cell therapy for treatment of type I diabetes, announced it has received International Standards Organization 13485: 2003 certification, an internationally recognized quality standard for medical devices.
For more information on this research see: Aerosol Deposition in the Human Lung in Reduced Gravity. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2014; 27 (3): 170-177. Journal of Aerosol Medicine and Pulmonary Drug Delivery can be contacted at: Mary Ann Liebert, Inc, 140 Huguenot Street, 3 RD Fl, New Rochelle, NY 10801, USA. ( Mary Ann
Findings from Hunan University Provides New Data about Drug Delivery Systems. According to news reporting out of Changsha, People's Republic of China, by NewsRx editors, research stated, "We present a facile approach to make aptamer-conjugated FRET nanoflowers through rolling circle replication for multiplexed cellular imaging and traceable targete
By a News Reporter-Staff News Editor at Biotech Week Icon Bioscience, Inc., a specialty biopharmaceutical company focused on utilizing its Verisome drug-delivery platform to develop unique intraocular eye-care therapeutics, announced the completion of patient enrollment in its pivotal phase 3 study of IBI-10090, approximately four months ahead
New Findings from University of Kentucky Yields New Data on Transdermal Delivery. By a News Reporter-Staff News Editor at Biotech Week Data detailed on Drugs and Therapies have been presented. The news reporters obtained a quote from the research from the University of Kentucky, "Wound healing literature has shown significant pH effects on barrie
Reports Outline Drug Delivery Systems Study Findings from University of Illinois. The news correspondents obtained a quote from the research from the University of Illinois, "The interactions that occur at the interface between NPs and biological components are complex, requiring a thorough understanding of the' nano-bio' interactions to design NPs
Research and Markets has announced the addition of the "Global Transdermal Drug Delivery Market 2014-2018" report to their offering. The Global Transdermal Drug Delivery market will grow at a CAGR of 9.9%. Transdermal drug delivery is a large and growing vertical market of the Pharmaceutical industry.
Studies in the Area of Drug Delivery Systems Reported from Department of Anesthesiology. According to news reporting originating in Rochester, Minnesota, by NewsRx journalists, research stated, "Intrathecal administration is an important route of drug delivery, and its modelling in a large animal species is of critical value. The news reporters obt
Study Results from Zhengzhou University in the Area of Drug Delivery Systems Reported. According to news reporting out of Zhengzhou, People's Republic of China, by NewsRx editors, research stated, "CaCO3/aliphatic poly/ sodium polystyrene sulfonate hybrid composites with dual-responsive controlled drug delivery property had been prepared via...